Somatic mosaicism in inherited bone marrow failure syndromes.

Best Pract Res Clin Haematol

Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, MD, USA.

Published: June 2021

Inherited bone marrow failure syndromes (IBMFS) are a heterogenous group of diseases caused by pathogenic germline variants in key pathways associated with haematopoiesis and genomic stability. Germline variants in IBMFS-related genes are known to reduce the fitness of hematopoietic stem and progenitor cells (HSPC), which has been hypothesized to drive clonal selection in these diseases. In many IBMFS, somatic mosaicism predominantly impacts cells by two distinct mechanisms, with contrasting effects. An acquired variation can improve cell fitness towards baseline levels, providing rescue of a deleterious phenotype. Alternatively, somatic mosaicism may result in a fitness advantage that results in malignant transformation. This review will describe these phenomena in IBMFS and delineate their relevance for diagnosis and clinical management. In addition, we will discuss which samples and methods can be used for detection of mosaicism according to clinical phenotype, type of mosaicism, and sample availability.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374086PMC
http://dx.doi.org/10.1016/j.beha.2021.101279DOI Listing

Publication Analysis

Top Keywords

somatic mosaicism
12
inherited bone
8
bone marrow
8
marrow failure
8
failure syndromes
8
germline variants
8
mosaicism inherited
4
syndromes inherited
4
syndromes ibmfs
4
ibmfs heterogenous
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!